Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
A multi-strain meningococcal B vaccine finally arrives in New Zealand
+Practice
In print
A multi-strain meningococcal B vaccine finally arrives in New Zealand
Wednesday 24 October 2018, 05:10 PM

Bexsero has been on the UK childhood schedule since September 2015
CHILD HEALTH
The availability of a meningococcal B vaccine is good news for New Zealand, as MenB is the most prevalent group and the burden of invasive meningococcal disease is high. The overseas experience is summarised here, as well as the recommendations for its use in New Zealand
Key points
-Group B meningococcal (MenB) disease is the most common type of invasive meningococcal disease in New Zealand, with the highest incide
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.